Security key
00791X209
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 1,271,217
- Total 13F value
- $585,730
- Share change
- -255,560
- SEC-reported price per share
- $0.76
- Number of holders
- 18
- Value change
- -$147,232
- Number of buys
- 7
- Number of sells
- 2
- Shares outstanding
- 11,898,571
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
18
Top holders
10
AEON full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
AEON Biopharma, Inc. SEC filings
AEON Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00791X209
Recent filing periods:
Ownership snapshot
Top reported holders of AEON - AEON Biopharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Jorey Chernett
Disclosed value leader
Dauntless Investment Grou...
Comparable rows
15/15
Latest evidence
27 May 2025
13D/G
13F
Lead comparable stake: 9.9%
13D/G row: Jorey Chernett
Showing 1-6 of 15 holder rows.
Quick read
Jorey Chernett leads the comparable SEC ownership view at 9.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Jorey Chernett's linked filing trail.
Comparable ownership
Top 5
Jorey Chernett
9.9%
Dauntless Investment Group, LLC
9.7%
BIGGER CAPITAL FUND L P
6.1%
PALMISANO ROBERT J
5.7%
L1 Capital Global Opportunities M...
4.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Jorey Chernett |
13D/G
Chernett Jorey
|
9.9%
|
$564,250
1,128,500 shares
|
$0 | 27 May 2025 |
| Dauntless Investment Group, LLC |
13F
13D/G
Company
|
9.7%
from 13D/G
|
$593,988
1,025,000 shares
|
— | 31 Mar 2025 |
| BIGGER CAPITAL FUND L P |
13D/G
Bigger Michael
|
6.1%
|
$343,000
4,900,000 shares
|
$0 | 06 Jan 2025 |
| PALMISANO ROBERT J |
13D/G
Robert J Palmisano
|
5.7%
|
$158,550
2,265,000 shares
|
$0 | 25 Jul 2024 |
| L1 Capital Global Opportunities Master Fund, Ltd. |
13D/G
|
4.1%
|
$32,552
465,029 shares
|
-$594,648 | 31 Mar 2025 |
| Blue Owl Capital Holdings LP |
13D/G
13F
Company
|
3.8%
|
$213,455
3,049,361 shares
|
$0 | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
18
Shares
1,271,217
Rows available
18
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
15
Q2 2025 holders
18
Holder diff
3
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend